Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phyto-chews is a branded cannabidiol (CBD) gummy product marketed as a hemp-derived dietary supplement, typically promoted for general wellness benefits such as relief of anxiety, stress, pain, and sleep disturbances rather than for any specific approved medical indication. These gummies contain phytocannabinoid-rich hemp extract (primarily cannabidiol) formulated in a chewable confectionery base, and act by modulating the endocannabinoid system, including cannabinoid receptors and related signaling pathways, to influence pain perception, mood, and sleep regulation. Phyto-chews products are generally positioned as over‑the‑counter nutraceuticals rather than regulated pharmaceuticals, and detailed composition, potency, and manufacturing standards may vary by vendor and jurisdiction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Phyto-chews.